POMELLA, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 1.492
AS - Asia 1.054
EU - Europa 692
SA - Sud America 165
AF - Africa 14
OC - Oceania 2
Totale 3.419
Nazione #
US - Stati Uniti d'America 1.445
SG - Singapore 515
IT - Italia 260
RU - Federazione Russa 160
BR - Brasile 132
CN - Cina 131
HK - Hong Kong 124
VN - Vietnam 76
JP - Giappone 63
DE - Germania 47
BD - Bangladesh 44
FI - Finlandia 40
GB - Regno Unito 36
NL - Olanda 34
IE - Irlanda 30
IN - India 25
CA - Canada 24
ID - Indonesia 24
FR - Francia 16
AR - Argentina 14
AT - Austria 14
MX - Messico 12
IQ - Iraq 10
PL - Polonia 10
EC - Ecuador 7
ES - Italia 7
SE - Svezia 7
TR - Turchia 7
LT - Lituania 6
MA - Marocco 6
PH - Filippine 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
GR - Grecia 4
MY - Malesia 4
PK - Pakistan 4
AL - Albania 3
CL - Cile 3
CO - Colombia 3
GT - Guatemala 3
IR - Iran 3
JM - Giamaica 3
TW - Taiwan 3
UZ - Uzbekistan 3
VE - Venezuela 3
AU - Australia 2
BE - Belgio 2
CZ - Repubblica Ceca 2
JO - Giordania 2
KE - Kenya 2
LV - Lettonia 2
PS - Palestinian Territory 2
PT - Portogallo 2
AW - Aruba 1
AZ - Azerbaigian 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
GD - Grenada 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
SR - Suriname 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
UY - Uruguay 1
Totale 3.419
Città #
Singapore 355
San Jose 160
Ashburn 125
Hong Kong 119
New York 95
Los Angeles 85
Council Bluffs 81
Chicago 78
Rome 78
Tokyo 59
The Dalles 57
Buffalo 49
Santa Clara 48
Beijing 47
Dublin 29
Ho Chi Minh City 27
Moscow 25
Dallas 24
Salt Lake City 24
Jakarta 23
Helsinki 22
Tampa 20
Lappeenranta 17
Nuremberg 16
Hanoi 15
São Paulo 15
Elk Grove Village 12
Phoenix 12
London 11
Orem 11
Montreal 10
Brooklyn 9
Monte Vista 9
Sterling 9
Vienna 9
Chennai 8
Denver 8
Frankfurt am Main 8
Mülheim 8
Wilmington 8
Atlanta 7
Center 7
Dulles 7
Munich 7
Stockholm 7
Warsaw 7
Boston 6
Brasília 6
Da Nang 6
Houston 6
Lancaster 6
Manchester 6
Milan 6
Seattle 6
Amsterdam 5
Ayn 5
Las Vegas 5
Miami 5
Pasadena 5
Pittsburgh 5
Redondo Beach 5
Bari 4
Belo Horizonte 4
Colorado Springs 4
Detroit 4
Foggia 4
Louisville 4
New Delhi 4
Palermo 4
Querétaro 4
San Francisco 4
Trento 4
Bauru 3
Catania 3
Coccaglio 3
Columbus 3
Guatemala City 3
Johannesburg 3
Manila 3
Mexico City 3
Monza 3
Mumbai 3
Poplar 3
Pune 3
Rabat 3
Shenzhen 3
Toronto 3
Acalanes Ridge 2
Amman 2
Ankara 2
Anápolis 2
Ardea 2
Baghdad 2
Bitonto 2
Boardman 2
Bom Despacho 2
Bình Dương 2
Campinas 2
Carney 2
Copenhagen 2
Totale 2.065
Nome #
About a Possible Impact of Endodontic Infections by Fusobacterium nucleatum or Porphyromonas gingivalis on Oral Carcinogenesis: A Literature Overview 204
Epigenetic remodelling in human hepatocellular carcinoma 173
New Insights on the Nuclear Functions and Targeting of FAK in Cancer 137
CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas 120
Radioresistance in rhabdomyosarcomas: much more than a question of dose 111
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting 103
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation 103
KDM3B inhibitors disrupt PAX3-FOXO1 oncogenic activity in fusion positive rhabdomyosarcoma 103
Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies 102
Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma 102
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma 101
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma 100
Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma 88
Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects 88
PAX3-FOXO1 establishes myogenic super enhancers and confers BET bromodomain vulnerability 87
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies 85
Effects of Angiogenic Factors on the Epithelial-to-Mesenchymal Transition and Their Impact on the Onset and Progression of Oral Squamous Cell Carcinoma: An Overview 84
Design of First-in-Class Dual {EZH}2/{HDAC} Inhibitor: biochemical activity and biological evaluation in cancer cells 83
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models 83
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 83
FAK Signaling in Rhabdomyosarcoma 82
Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma 81
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 80
Dose-dependent activation of gene expression is achieved using CRISPR and small molecules that recruit endogenous chromatin machinery 79
MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells 78
The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview 76
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks 72
SNAI2-mediated repression of BIM protects rhabdomyosarcoma from ionizing radiation 70
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 69
DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma 69
Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma 67
MET inhibition sensitizes rhabdomyosarcoma cells to NOTCH signaling suppression 62
Epigenetic determinants of fusion-driven sarcomas: paradigms and challenges 62
Miswired Enhancer Logic Drives a Cancer of the Muscle Lineage 60
MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma 59
Small heat-shock protein HSPB3 promotes myogenesis by regulating the lamin B receptor 59
Chemical genomics reveals histone deacetylases are required for core regulatory transcription 55
Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma 55
Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3–FOXO1 rhabdomyosarcoma 48
The CRISP(Y) Future of Pediatric Soft Tissue Sarcomas 39
The HIV Protease Inhibitor Ritonavir Reverts the Mesenchymal Phenotype Induced by Inflammatory Cytokines in Normal and Tumor Oral Keratinocytes to an Epithelial One, Increasing the Radiosensitivity of Tumor Oral Keratinocytes 37
Heat Shock Proteins: Important Helpers for the Development, Maintenance and Regeneration of Skeletal Muscles 34
Ritonavir and DNA Damage: A New Perspective on an Old Drug 33
Inhibition of bromodomain and extra-terminal motif (BET) proteins in pediatric sarcoma: A systematic review of in vitro and in vivo studies 29
Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma 12
Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells 11
From bench to bedside: combining HDAC inhibitors with standard therapies in rhabdomyosarcoma treatment 11
Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer 11
Fibronectin Is a Likely Therapeutic Target Shared by Oral and Breast Carcinomas 9
Totale 3.649
Categoria #
all - tutte 18.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.777


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023219 0 0 4 1 0 1 129 11 8 28 31 6
2023/2024144 4 2 6 4 10 52 23 5 7 3 2 26
2024/20251.321 21 215 146 56 9 171 59 41 41 311 205 46
2025/20261.965 158 105 137 179 214 78 217 225 261 137 167 87
Totale 3.649